Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 1895

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.


Publication type: Journal Article

The fine line between education and marketing..
Proj Inf Perspect 1999 Sep 01; (28):1-3


AIDS: Doctors and AIDS activists have long been the target of marketing by the pharmaceutical industry. More recently, pharmaceutical companies have directed their marketing at case managers, hotline operators, and other individuals with access to harder-to-reach populations. This marketing takes the form of community meetings and targets carefully selected groups or treatment education programs and emphasizes the use of certain products. Such programs may be tempting for financially strained AIDS agencies. However, the AIDS community should be critical of the role that the pharmaceutical industry plays in disease and treatment education. Suggestions on how the needs of the pharmaceutical industry can be balanced with the needs of the AIDS community are provided.

Acquired Immunodeficiency Syndrome/drug therapy* Anti-HIV Agents/therapeutic use* Drug Industry* Humans Marketing of Health Services*/methods Patient Education*/methods United States


  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Click to Register

(read more)

Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.